Drug Facts
Composition & Profile
Identifiers & Packaging
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Meclizine Hydrochloride Tablets USP, 12.5 mg are supplied as light blue colored, oval shaped tablets with “AN 441” debossed on one side and plain on the other side. They are available as follows: Unit dose packages of 100 (10 x 10) NDC 60687-775-01 Unit dose packages of 50 (5 x 10) NDC 60687-775-65 Meclizine Hydrochloride Tablets USP, 25 mg are supplied as light yellow colored, oval shaped tablets with “AN 442” debossed on one side and plain on the other side. They are available as follows: Unit dose packages of 100 (10 x 10) NDC 60687-730-01 Unit dose packages of 50 (5 x 10) NDC 60687-730-65 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. Keep this and all medication out of the reach of children.; Package/Label Display Panel – Carton – 12.5 mg, 50 UD NDC 60687- 775 -65 Meclizine Hydrochloride Tablets, USP 12.5 mg* 50 Tablets (5 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................12.5 mg (equivalent to 10.53 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-441, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 777565 0477565/1023 12.5 mg Meclizine Hydrochloride Tablets Carton-50UD; Package/Label Display Panel – Carton – 12.5 mg, 100 UD NDC 60687- 775 -01 Meclizine Hydrochloride Tablets, USP 12.5 mg* 100 Tablets (10 x 10) Rx Only *Each Tablet Contains: Meclizine Dihydrochloride, USP............................................12.5 mg (equivalent to 10.53 mg of meclizine free base.) Usual Dosage: See package insert for full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep this and all drugs out of reach of children. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-441, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging Columbus, Ohio 43217 777501 0477501/0623 12.5 mg Meclizine Hydrochloride Tablets Carton-100UD; Package/Label Display Panel – Blister – 12.5 mg Meclizine Hydrochloride Tablet, USP 12.5 mg 12.5 mg Meclizine Hydrochloride Tablet Blister; Package/Label Display Panel – Carton – 25 mg, 50UD NDC 60687- 730 -65 Meclizine Hydrochloride Tablets, USP 25 mg* 50 Tablets (5 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................... 25 mg (equivalent to 21.07 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-442, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 773065 0473065/1023 25 mg Meclizine Hydrochloride Tablets Carton-50UD; Package/Label Display Panel – Carton – 25 mg, 100 UD NDC 60687- 730 -01 Meclizine Hydrochloride Tablets, USP 25 mg* 100 Tablets (10 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................... 25 mg (equivalent to 21.07 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-442, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 773001 0473001/1123 25 mg Meclizine Hydrochloride Tablets Carton-100 UD; Package/Label Display Panel – Blister – 25 mg Meclizine Hydrochloride Tablet, USP 25 mg 25 mg Meclizine Hydrochloride Tablet Blister
- 16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Meclizine Hydrochloride Tablets USP, 12.5 mg are supplied as light blue colored, oval shaped tablets with “AN 441” debossed on one side and plain on the other side. They are available as follows: Unit dose packages of 100 (10 x 10) NDC 60687-775-01 Unit dose packages of 50 (5 x 10) NDC 60687-775-65 Meclizine Hydrochloride Tablets USP, 25 mg are supplied as light yellow colored, oval shaped tablets with “AN 442” debossed on one side and plain on the other side. They are available as follows: Unit dose packages of 100 (10 x 10) NDC 60687-730-01 Unit dose packages of 50 (5 x 10) NDC 60687-730-65 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. Keep this and all medication out of the reach of children.
- Package/Label Display Panel – Carton – 12.5 mg, 50 UD NDC 60687- 775 -65 Meclizine Hydrochloride Tablets, USP 12.5 mg* 50 Tablets (5 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................12.5 mg (equivalent to 10.53 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-441, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 777565 0477565/1023 12.5 mg Meclizine Hydrochloride Tablets Carton-50UD
- Package/Label Display Panel – Carton – 12.5 mg, 100 UD NDC 60687- 775 -01 Meclizine Hydrochloride Tablets, USP 12.5 mg* 100 Tablets (10 x 10) Rx Only *Each Tablet Contains: Meclizine Dihydrochloride, USP............................................12.5 mg (equivalent to 10.53 mg of meclizine free base.) Usual Dosage: See package insert for full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep this and all drugs out of reach of children. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-441, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging Columbus, Ohio 43217 777501 0477501/0623 12.5 mg Meclizine Hydrochloride Tablets Carton-100UD
- Package/Label Display Panel – Blister – 12.5 mg Meclizine Hydrochloride Tablet, USP 12.5 mg 12.5 mg Meclizine Hydrochloride Tablet Blister
- Package/Label Display Panel – Carton – 25 mg, 50UD NDC 60687- 730 -65 Meclizine Hydrochloride Tablets, USP 25 mg* 50 Tablets (5 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................... 25 mg (equivalent to 21.07 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-442, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 773065 0473065/1023 25 mg Meclizine Hydrochloride Tablets Carton-50UD
- Package/Label Display Panel – Carton – 25 mg, 100 UD NDC 60687- 730 -01 Meclizine Hydrochloride Tablets, USP 25 mg* 100 Tablets (10 x 10) Rx Only *Each Tablet Contains: Meclizine dihydrochloride, USP ............................................... 25 mg (equivalent to 21.07 mg of meclizine free base.) Usual Dosage: See full prescribing information. VERTIGO: 25 mg to 100 mg in divided doses daily depending on the clinical response. Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken. The drug product contained in this package is from NDC # 53746-442, Amneal Pharmaceuticals LLC. Distributed by: American Health Packaging, Columbus, Ohio 43217 773001 0473001/1123 25 mg Meclizine Hydrochloride Tablets Carton-100 UD
- Package/Label Display Panel – Blister – 25 mg Meclizine Hydrochloride Tablet, USP 25 mg 25 mg Meclizine Hydrochloride Tablet Blister
Overview
Meclizine hydrochloride, a histamine (H1) receptor antagonist, is a white or slightly yellowish, crystalline powder. Its molecular formula is C 25 H 27 ClN 2 •2HCl•H 2 O and its molecular weight is 481.88. It has the following structural formula: Chemically, meclizine hydrochloride is 1-( p -chloro-α-phenylbenzyl)-4-( m -methylbenzyl) piperazine dihydrochloride monohydrate. Each meclizine hydrochloride 12.5 mg tablet contains 12.5 mg of meclizine dihydrochloride equivalent to 10.53 mg of meclizine free base. Each meclizine hydrochloride 25 mg tablet contains 25 mg of meclizine dihydrochloride equivalent to 21.07 mg of meclizine free base. Inactive ingredients for the tablets are: colloidal silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium starch glycolate and talc. The 12.5 mg tablets also contain FD&C Blue #1 Aluminum Lake. The 25 mg tablets also contain D&C Yellow #10 Aluminum Lake. Structural Formula
Indications & Usage
Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults. Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults (1) .
Dosage & Administration
Recommended dosage: 25 mg to 100 mg daily, in divided doses (2.1) . Tablets: Swallow whole (2.2) . 2.1 Recommended Dosage The recommended dosage is 25 mg to 100 mg daily administered orally, in divided doses, depending upon clinical response. 2.2 Administration Instructions Tablets Meclizine hydrochloride tablets must be swallowed whole.
Warnings & Precautions
May cause drowsiness: Use caution when driving a car or operating dangerous machinery (5.1) . Potential anticholinergic action: this drug should be prescribed with care to patients with a history of asthma, glaucoma, or enlargement of the prostate gland (5.2) . 5.1 Drowsiness Since drowsiness may occur with use of meclizine hydrochloride, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery. Patients should avoid alcoholic beverages while taking meclizine hydrochloride [see Drug Interactions (7.1) ]. 5.2 Concurrent Medical Conditions Because of its potential anticholinergic action, meclizine hydrochloride should be used with caution in patients with asthma, glaucoma, or enlargement of the prostate gland.
Contraindications
Meclizine hydrochloride tablets are contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients [see Adverse Reactions (6) and Description (11) ]. Meclizine hydrochloride tablets are contraindicated in patients with hypersensitivity to meclizine or any of the inactive ingredients (4) .
Adverse Reactions
The following adverse reactions associated with the use of meclizine hydrochloride were identified in clinical studies or post-marketing reports. Because some of these reactions were reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported. Common adverse reactions are anaphylactic reaction, drowsiness, dry mouth, headache, fatigue, and vomiting. On rare occasions blurred vision has been reported (6) . To report SUSPECTED ADVERSE REACTIONS, contact Amneal Pharmaceuticals at 1-877-835-5472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
Drug Interactions
Co-administration of meclizine hydrochloride with other CNS depressants, including alcohol, may result in increased CNS depression (7.1) . CYP2D6 inhibitors: As meclizine is metabolized by CYP2D6, there is a potential for drug-drug interactions between meclizine hydrochloride and CYP2D6 inhibitors (7.2) . 7.1 CNS Depressants There may be increased CNS depression when meclizine hydrochloride is administered concurrently with other CNS depressants, including alcohol [see Warnings and Precautions (5.1) ]. 7.2 CYP2D6 Inhibitors Based on in-vitro evaluation, meclizine is metabolized by CYP2D6. Therefore, there is a possibility for a drug interaction between meclizine hydrochloride and CYP2D6 inhibitors. Therefore, monitor for adverse reactions and clinical effect accordingly.
Similar Drugs
Related medications based on brand, generic name, substance, active ingredients.